Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bacchetti

Showing results (191-200 of 246) with videos related to

Pageof 25
Sort By:
AIDS Research and Human Retroviruses|November 13, 2012
Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletionCarina L Perez, Jeffrey M Milush, Marcus Buggert, et al.
The Journal of Infectious Diseases|August 29, 2012
A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected womenMonica Gandhi, Ruth M Greenblatt, Peter Bacchetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 16, 2018
Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort StudyKendra K Radtke, Peter Bacchetti, Kathryn Anastos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 9, 2014
Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measuresSanjiv M Baxi, Albert Liu, Peter Bacchetti, et al.
AIDS (London, England)|July 31, 2010
Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thicknessJoseph A C Delaney, Rebecca Scherzer, Mary L Biggs, et al.
Eclinicalmedicine|March 26, 2019
Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral AdherenceMonica Gandhi, Peter Bacchetti, Warren C Rodrigues, et al.
The Journal of Infectious Diseases|July 16, 2013
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeVivek Jain, Wendy Hartogensis, Peter Bacchetti, et al.
JCI Insight|February 12, 2020
Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapyMichael J Peluso, Peter Bacchetti, Kristen D Ritter, et al.
Plos One|December 8, 2017
Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosisVidya Mave, Aarti Kinikar, Anju Kagal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2022
Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in HairTeacler G Nematadzira, Pamela M Murnane, Osamuedeme J Odiase, et al.
Pageof 25

Showing results (191-200 of 246) with videos related to

Sort By:
Pageof 25
AIDS Research and Human Retroviruses|November 13, 2012
Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletionCarina L Perez, Jeffrey M Milush, Marcus Buggert, et al.
The Journal of Infectious Diseases|August 29, 2012
A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected womenMonica Gandhi, Ruth M Greenblatt, Peter Bacchetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 16, 2018
Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort StudyKendra K Radtke, Peter Bacchetti, Kathryn Anastos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 9, 2014
Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measuresSanjiv M Baxi, Albert Liu, Peter Bacchetti, et al.
AIDS (London, England)|July 31, 2010
Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thicknessJoseph A C Delaney, Rebecca Scherzer, Mary L Biggs, et al.
Eclinicalmedicine|March 26, 2019
Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral AdherenceMonica Gandhi, Peter Bacchetti, Warren C Rodrigues, et al.
The Journal of Infectious Diseases|July 16, 2013
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeVivek Jain, Wendy Hartogensis, Peter Bacchetti, et al.
JCI Insight|February 12, 2020
Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapyMichael J Peluso, Peter Bacchetti, Kristen D Ritter, et al.
Plos One|December 8, 2017
Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosisVidya Mave, Aarti Kinikar, Anju Kagal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2022
Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in HairTeacler G Nematadzira, Pamela M Murnane, Osamuedeme J Odiase, et al.
Pageof 25